07:00 , Apr 18, 2011 |  BC Week In Review  |  Company News

Auric Pharma, Neuro-Biotech Corp. deal

Neuro-Biotech said its board has decided not to proceed with Auric's offer to acquire all outstanding shares of the biotech after the companies were unable to agree on a common direction for Neuro-Biotech. In February,...
07:00 , Apr 4, 2011 |  BC Week In Review  |  Company News

Auric Pharma, Neuro-Biotech Corp. deal

Auric will complete its previously announced acquisition of Neuro-Biotech on April 5. Both parties accepted the terms of the deal and completed due diligence. Neuro-Biotech's president and CEO, Boris Oleknovich, will become president of the...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Company News

Auric Pharma, Neuro-Biotech deal

Following the completion of preliminary due diligence, Neuro-Biotech decided it is not in the best interest of the company to proceed with negotiations regarding Auric's offer to acquire all outstanding shares of the biotech for...
08:00 , Feb 21, 2011 |  BC Week In Review  |  Company News

Auric Pharma, Neuro-Biotech Corp. deal

Neuro-Biotech's board has accepted Auric's previously announced offer to acquire all outstanding shares of the biotech for $0.15 per share, or about $99.4 million. The price is a 400% premium to Neuro-Biotech's close of $0.03...